Tag: disease-modifying treatment (DMT)

Asymptomatic women at high risk for Multiple Sclerosis may have early subclinical neuroimaging abnormalities

Early intensive treatment of multiple sclerosis associated with slower progression of disability

byJames Englandand1 others

February 25, 2019

1. In this prospective cohort study of patients with multiple sclerosis, upfront use of highly-efficacious disease modifying therapies (DMTs) compared ...

#VisualAbstract: Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis

#VisualAbstract: Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

byStudy Graphics | C.Wuand1 others

September 6, 2020

1. In this case-control cohort study, treatment with glatiramer acetate, interferon-beta, fingolimod, alemtuzumab, and natalizumab all led to reduced conversion ...

Disease modifying therapies likely to reduce conversion to secondary progressing multiple sclerosis

byDaniel Fisher

January 16, 2019

1. In this case-control cohort study, treatment with glatiramer acetate, interferon-beta, fingolimod, alemtuzumab, and natalizumab all led to reduced conversion ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result